Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Amyris, Inc. To Contact The Firm

NEW YORK, June 29, 2013

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO )

The investigation focuses on whether the Company and its executives violated federal securities laws with respect to its disclosures concerning business, operational, and compliance policies.  Specifically, the investigation focuses on whether Amyris made false and misleading statements to the investing public regarding its ability to produce Biofene, a renewable chemical. 

On February 9, 2012, the Company disclosed that there would be a decrease in Biofene production and that it needed to raise funds.  Following this news, Amyris' stock dropped $2.74, or over 28%.

Request more information now by clicking here: www.faruqilaw.com/AMRS.  There is no cost or obligation to you.

Take Action

If you invested in Amyris' stock or options between April 29, 2011 and February 8, 2012 and would like to discuss your legal rights, visit www.faruqilaw.com/AMRS.  You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Amyris' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.